The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy

被引:76
作者
Li, M. [1 ,2 ]
Yu, X. [2 ]
机构
[1] Peking Univ, Hosp 3, Reprod Med Ctr, Dept Obstet & Gynecol, Beijing 100871, Peoples R China
[2] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA
关键词
DOUBLE-STRAND BREAKS; NUCLEOTIDE EXCISION-REPAIR; SEVERE COMBINED IMMUNODEFICIENCY; HISTONE ADP-RIBOSYLATION; HOMOLOGY-DIRECTED REPAIR; ATM PROTEIN-KINASE; DOMAIN BARD1 GENE; RING DOMAIN; POLYNUCLEOTIDE KINASE; BRCT DOMAIN;
D O I
10.1038/onc.2014.295
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DNA damage is a deleterious threat, but occurs daily in all types of cells. In response to DNA damage, poly(ADP-ribosyl)ation, a unique post-translational modification, is immediately catalyzed by poly(ADP-ribose) polymerases (PARPs) at DNA lesions, which facilitates DNA damage repair. Recent studies suggest that poly(ADP-ribosyl) ation is one of the first steps of cellular DNA damage response and governs early DNA damage response pathways. Suppression of DNA damage-induced poly(ADP-ribosyl) ation by PARP inhibitors impairs early DNA damage response events. Moreover, PARP inhibitors are emerging as anti-cancer drugs in phase III clinical trials for BRCA-deficient tumors. In this review, we discuss recent findings on poly(ADP-ribosyl) ation in DNA damage response as well as the molecular mechanism by which PARP inhibitors selectively kill tumor cells with BRCA mutations.
引用
收藏
页码:3349 / 3356
页数:8
相关论文
共 142 条
[1]   Poly(ADP-ribose)-Dependent Regulation of DNA Repair by the Chromatin Remodeling Enzyme ALC1 [J].
Ahel, Dragana ;
Horejsi, Zuzana ;
Wiechens, Nicola ;
Polo, Sophie E. ;
Garcia-Wilson, Elisa ;
Ahel, Ivan ;
Flynn, Helen ;
Skehel, Mark ;
West, Stephen C. ;
Jackson, Stephen P. ;
Owen-Hughes, Tom ;
Boulton, Simon J. .
SCIENCE, 2009, 325 (5945) :1240-1243
[2]   Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins [J].
Ahel, Ivan ;
Ahel, Dragana ;
Matsusaka, Takahiro ;
Clark, Allison J. ;
Pines, Jonathon ;
Boulton, Simon J. ;
West, Stephen C. .
NATURE, 2008, 451 (7174) :81-U12
[3]   The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates [J].
Ahel, Ivan ;
Rass, Ulrich ;
El-Khamisy, Sherif F. ;
Katyal, Sachin ;
Clements, Paula M. ;
McKinnon, Peter J. ;
Caldecott, Keith W. ;
West, Stephen C. .
NATURE, 2006, 443 (7112) :713-716
[4]   The zinc-finger domains of PARP1 cooperate to recognize DNA strand breaks [J].
Ali, Ammar A. E. ;
Timinszky, Gyula ;
Arribas-Bosacoma, Raquel ;
Kozlowski, Marek ;
Hassa, Paul O. ;
Hassler, Markus ;
Ladurner, Andreas G. ;
Pearl, Laurence H. ;
Oliver, Antony W. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2012, 19 (07) :685-+
[5]   CHARACTERIZATION OF POLYMERS OF ADENOSINE-DIPHOSPHATE RIBOSE GENERATED INVITRO AND INVIVO [J].
ALVAREZGONZALEZ, R ;
JACOBSON, MK .
BIOCHEMISTRY, 1987, 26 (11) :3218-3224
[6]   POLY(ADP-RIBOSE) CATABOLISM IN MAMMALIAN-CELLS EXPOSED TO DNA-DAMAGING AGENTS [J].
ALVAREZGONZALEZ, R ;
ALTHAUS, FR .
MUTATION RESEARCH, 1989, 218 (02) :67-74
[7]   ENZYMOLOGY OF ADP-RIBOSE POLYMER SYNTHESIS [J].
ALVAREZGONZALEZ, R ;
PACHECORODRIGUEZ, G ;
MENDOZAALVAREZ, H .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1994, 138 (1-2) :33-37
[8]   The PARP superfamily [J].
Amé, JC ;
Spenlehauer, C ;
de Murcia, G .
BIOESSAYS, 2004, 26 (08) :882-893
[9]   A synthetic lethal therapeutic approach: Poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair [J].
Ashworth, Alan .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) :3785-3790
[10]   Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial [J].
Audeh, M. William ;
Carmichael, James ;
Penson, Richard T. ;
Friedlander, Michael ;
Powell, Bethan ;
Bell-McGuinn, Katherine M. ;
Scott, Clare ;
Weitzel, Jeffrey N. ;
Oaknin, Ana ;
Loman, Niklas ;
Lu, Karen ;
Schmutzler, Rita K. ;
Matulonis, Ursula ;
Wickens, Mark ;
Tutt, Andrew .
LANCET, 2010, 376 (9737) :245-251